Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciro Gallo

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|August 6, 2011
Prognosis of CKD patients receiving outpatient nephrology care in ItalyLuca De Nicola, Paolo Chiodini, Carmine Zoccali, et al.
Age (Dordrecht, Netherlands)|April 12, 2011
Pulse wave velocity is associated with muscle mass decline: Health ABC studyAngela Marie Abbatecola, Paolo Chiodini, Ciro Gallo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancerMassimo Di Maio, Paolo Chiodini, Vassilis Georgoulias, et al.
Clinical Lung Cancer|May 23, 2016
BEVERLY: Rationale and Design of a Randomized Open-Label Phase III Trial Comparing Bevacizumab Plus Erlotinib Versus Erlotinib Alone as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous Non-Small-Cell Lung CancerCesare Gridelli, Antonio Rossi, Fortunato Ciardiello, et al.
Journal of Clinical Gastroenterology|December 19, 2002
Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma: a Cancer of the Liver Italian Program (CLIP 08) retrospective case-control studyBruno Daniele, Ilario De Sio, Francesco Izzo, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2014
Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancerNicola Normanno, Antonio Rossi, Alessandro Morabito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancerSabino De Placido, Michelino De Laurentiis, Chiara Carlomagno, et al.
Cancer Chemotherapy and Pharmacology|March 7, 2009
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trialCarmela Pisano, Alessandro Morabito, Roberto Sorio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studiesCesare Gridelli, Paolo Maione, Alfonso Illiano, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensive-stage small-cell lung cancer: a poorly tolerated regimen. Results of a multicentre phase II studyCesare Gridelli, Antonio Rossi, Emiddio Barletta, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Clinical Journal of the American Society of Nephrology : CJASN|August 6, 2011
Prognosis of CKD patients receiving outpatient nephrology care in ItalyLuca De Nicola, Paolo Chiodini, Carmine Zoccali, et al.
Age (Dordrecht, Netherlands)|April 12, 2011
Pulse wave velocity is associated with muscle mass decline: Health ABC studyAngela Marie Abbatecola, Paolo Chiodini, Ciro Gallo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancerMassimo Di Maio, Paolo Chiodini, Vassilis Georgoulias, et al.
Clinical Lung Cancer|May 23, 2016
BEVERLY: Rationale and Design of a Randomized Open-Label Phase III Trial Comparing Bevacizumab Plus Erlotinib Versus Erlotinib Alone as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous Non-Small-Cell Lung CancerCesare Gridelli, Antonio Rossi, Fortunato Ciardiello, et al.
Journal of Clinical Gastroenterology|December 19, 2002
Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma: a Cancer of the Liver Italian Program (CLIP 08) retrospective case-control studyBruno Daniele, Ilario De Sio, Francesco Izzo, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2014
Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancerNicola Normanno, Antonio Rossi, Alessandro Morabito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancerSabino De Placido, Michelino De Laurentiis, Chiara Carlomagno, et al.
Cancer Chemotherapy and Pharmacology|March 7, 2009
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trialCarmela Pisano, Alessandro Morabito, Roberto Sorio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studiesCesare Gridelli, Paolo Maione, Alfonso Illiano, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensive-stage small-cell lung cancer: a poorly tolerated regimen. Results of a multicentre phase II studyCesare Gridelli, Antonio Rossi, Emiddio Barletta, et al.
Pageof 12